Abstract
Primary extranodal lymphoma of the breast is rare and accounts for 0.04 - 0.53% of all malignant tumours, less than 1% of non-Hodgkin’s lymphomas (NHLs) and 1.7% of extranodal NHLs.1 Extranodal lymphoma arises from tissue other than lymph nodes and sites that normally contain no lymphoid tissue. This case describes the clinical and treatment dilemma posed by extranodal presentation in an AIDS-NHL patient.
Highlights
Cerebrospinal fluid (CSF) examination was negative for lymphoma infiltration
CHEMOTHERAPY The standard CHOP regimen consisting of cyclophosphamide 750 mg/ m2, doxorubicin 50 mg/m2 and vincristine 1.4 mg/m2 on day 1 and prednisone 60 mg/day on days 1 - 5 every 3 weeks was started
The left axillary lymph node and breast mass had the appearance of breast cancer with erythema, oedema and nipple retraction
Summary
Primary extranodal lymphoma of the breast is rare and accounts for 0.04 - 0.53% of all malignant tumours, less than 1% of non-Hodgkin’s lymphomas (NHLs) and 1.7% of extranodal NHLs.[1]. CASE REPORT A 40-year-old woman presented with a history of a painful left axillary mass that had progressively increased in size. Physical examination revealed a 17×13 cm left axillary nodal mass.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
